Cargando…

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease

Detalles Bibliográficos
Autores principales:	Kim, Kwang Woo, Kang, Hyoun Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626016/ https://www.ncbi.nlm.nih.gov/pubmed/37915177 http://dx.doi.org/10.5217/ir.2023.00133

Ejemplares similares

Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
por: Park, Yong Eun
Publicado: (2022)

Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children
por: Yoon, Jisun, et al.
Publicado: (2015)

Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
por: Kim, You Sun, et al.
Publicado: (2023)

Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
por: Singh, Arshdeep, et al.
Publicado: (2023)

Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
por: Da Cunha, Teresa, et al.
Publicado: (2022)

Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Fousekis, Fotios S., et al.
Publicado: (2019)

Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence
por: Mertz, Andrew, et al.
Publicado: (2019)

The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Lynch, Kate D., et al.
Publicado: (2019)

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
por: Lynch, Kate D., et al.
Publicado: (2020)

Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis
por: Bjarnason, Ingvar, et al.
Publicado: (2015)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Tissue-dependent transcriptional and bacterial associations in primary sclerosing cholangitis-associated inflammatory bowel disease
por: Ilott, Nicholas E., et al.
Publicado: (2022)

The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival
por: Chahal, Daljeet, et al.
Publicado: (2020)

Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
por: de Krijger, Manon, et al.
Publicado: (2022)

Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease
por: Wang, Ming-Hsi, et al.
Publicado: (2023)

Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features
por: Palmela, Carolina, et al.
Publicado: (2018)

Geoepidemiologic variation in outcomes of primary sclerosing cholangitis
por: Mehta, Tej I, et al.
Publicado: (2020)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

Inflammatory Bowel Disease and Primary Sclerosing Cholangitis in a Pediatric Patient With Neurofibromatosis Type 1
por: Lehan, Emily, et al.
Publicado: (2021)

Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease
por: Gwela, Agnes, et al.
Publicado: (2017)

Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease
por: Weng, Meng-Tzu, et al.
Publicado: (2022)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel Disease
por: Chung, Brian K., et al.
Publicado: (2018)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Diagnostic yield of endomicroscopy for dysplasia in primary sclerosing cholangitis associated inflammatory bowel disease: a feasibility study
por: Dlugosz, Aldona, et al.
Publicado: (2016)

Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease
por: Bajer, Lukas, et al.
Publicado: (2018)

Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis
por: Dyson, Jessica Katharine, et al.
Publicado: (2020)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Primary sclerosing cholangitis and pregnancy
por: Kammeijer, Casper Q., et al.
Publicado: (2011)

An Overview on Primary Sclerosing Cholangitis
por: Vlăduţ, Cătălina, et al.
Publicado: (2020)

Endothelin Signaling Mediates Biliary-Endothelial Crosstalk in Primary Sclerosing Cholangitis
por: Yin, Chunyue
Publicado: (2023)

Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis
por: Kim, You Sun, et al.
Publicado: (2023)

Frequency and risk factors of primary sclerosing cholangitis among patients with inflammatory bowel disease in North-East of Iran
por: Khosravi Khorashad, Ahmad, et al.
Publicado: (2015)

Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis
por: Mouchli, Mohamad A, et al.
Publicado: (2018)

Tumor Necrosis Factor Alpha Inhibition for Inflammatory Bowel Disease after Liver Transplant for Primary Sclerosing Cholangitis
por: Parekh, Ravish, et al.
Publicado: (2018)

A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis
por: Vaughn, Byron P, et al.
Publicado: (2019)

Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease
por: de Krijger, Manon, et al.
Publicado: (2020)

Nivolumab-related Sclerosing Cholangitis in Gastric Cancer
por: Motoo, Yoshiharu
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cplpqfc05gm9c3181g7cfrlh7n